114527-54-7 Usage
General Description
1,2,3,4-Tetrahydroquinoline-5-carboxylic acid is a chemical compound with the molecular formula C11H13NO2. It is a derivative of tetrahydroquinoline, which is a bicyclic compound with a quinoline core. This chemical has potential applications in medicinal chemistry, as it may have biological activity that could be useful in drug development. It also has potential uses in the synthesis of various organic compounds. The presence of a carboxylic acid group in the molecule means that it can participate in a variety of chemical reactions, making it a versatile building block for organic synthesis. Its unique structure and functional groups make it an intriguing compound for further study and potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 114527-54-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,5,2 and 7 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 114527-54:
(8*1)+(7*1)+(6*4)+(5*5)+(4*2)+(3*7)+(2*5)+(1*4)=107
107 % 10 = 7
So 114527-54-7 is a valid CAS Registry Number.
114527-54-7Relevant articles and documents
Reduction of Quinolinecarboxylic Acids by Raney Alloy
Gracheva, I. N.,Tochilkin, A. I.
, p. 65 - 67 (1988)
The heterocyclic nucleus in quinolinecarboxylic acids is reduced by Raney alloy (nickel-aluminium) in alkaline media to give 1,2,3,4-tetrahydro-2-,3-,4-,5-,6-, and 8-quinolinecarboxylic acids and 8-methyl-5-quinolinecarboxylic acid and their ethyl esters.
Heterocyclic compounds as bradykinin antagonists
-
, (2008/06/13)
This invention relates to a compound of formula (I) wherein A1 is lower alkylene, R1 is substituted quinolyl, etc., R2 is hydrogen, halogen or lower alkyl, R3 is halogen or lower alkyl, and R4 is a gr
HIV protease inhibitors
-
, (2008/06/13)
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optionally other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.
